Slingshot members are tracking this event:
Global Blood Therapeutics Announces Presentation of New GBT440 Data in Sickle Cell Disease at the European Hematology Association's 21st Congress
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
|GBT||Community voting in process|
Slingshot Insights Explained
May 19, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Gbt440, Sickle Cell Disease, Gbt440-001, Oxygenated Sickle Hemoglobin, Polymerize, Red Blood Cells